DiaMonTech submits to FDA pre-submission application for non-invasive blood glucose meter D-Base

Berlin, 9 September 2020

With the submission of the pre-submissionapplication to the US Food and Drug Administration (FDA), the company has initiated the approval process of its product D-Base as a medical device in the US.

D-Base uses the innovative DiaMonTech technology for non-invasive, precise,and painless measurement of blood glucose levels and it is optimized for use in professional environments such as diabetes centers.

For diabetes patients and prediabetics, DiaMonTech is developing the smaller D-Pocket, which builds on the same laser technology.

In the next step of the approval process, DiaMonTech will align with the FDA on the regulatory approval path for the US.

About DiaMonTech
DiaMonTech AG is a medical technology company that specializes in the development, design and sale of products for medical diagnostics. The patented photothermal diagnostic technology based on infrared lasers enables the precise measurement of relevant blood parameters. The first application is the non-invasive blood glucose measurement, which enables an accurate and fast measurement without pain.

More information about DiaMonTech can be found at www.diamontech.de.

Press contact
Alexander Neblung
Kirchhoff Consult AG
Phone +49 40 60 91 86 70
E-mail diamontech@kirchhoff.de

Life is on!

Stay tuned and get updates.

We are working hard in our lab day and night but it takes some time to develop a new medical device. Subscribe to our newsletter to get the latest news.

Notify me